| ID | Sequence | Length | GC content |
|---|---|---|---|
| PRKCQ-AS1:55 | AAUUGCUUUAUCUACCAAUCCUAAACUAUUAUAUCUUGAUCUUUACUCA… | 400 nt | 0.3750 |
| PRKCQ-AS1:56 | GUUAUGAAAUUAUAAAUGGUGCCCAGAUGAACAACCACACUGAGUACAA… | 231 nt | 0.4892 |
| PRKCQ-AS1:57 | UGUGUGGCUUCCUCCACCCAUUAAUUGUAAUUCUAGCAGUUGGGGCCAU… | 315 nt | 0.4889 |
| PRKCQ-AS1:6 | AGCCAGGGACGCGCGCUCGGUCCCCCGCCGUGCGCCCCCGGUCCCGCGC… | 2253 nt | 0.4212 |
| PRKCQ-AS1:7 | GGUCCCCCGCCGUGCGCCCCCGGUCCCGCGCCCAGGCUCCCGCCCCUGG… | 3855 nt | 0.3901 |
| PRKCQ-AS1:8 | CCUUACCAGCCACUUGUCGCCCAGCUGCGAACUGGAGCGGGAGGCGGCG… | 915 nt | 0.5202 |
| PRKCQ-AS1:9 | UUGUCGCCCAGCUGCGAACUGGAGCGGGAGGCGGCGGCCGGAGGGCCCA… | 3825 nt | 0.3880 |
No relevant information is available at the moment.
A study in human postmortem midbrain specimens from chronic cocaine abusers identified the PRKCQ-AS1 as a significantly down-regulated long noncoding RNA (-1.33-fold) in cocaine abusers compared to matched controls [Bannon et al. DOI:10.1111/jnc.13255]. A review further notes the PRKCQ-AS1 as a biomarker significantly altered in cocaine abusers, highlighting its association with drug abuse disorders [Das et al. DOI:10.1080/21655979.2021.2003667].